What is a stock summary page? Click here for an overview.
Business Description
ESSA Pharma Inc
NAICS : 325412
SIC : 3741
ISIN : CA29668H7085
Description
ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 394.92 | |||||
| Equity-to-Asset | 0.97 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 12.3 | |||||
| 3-Year EPS without NRI Growth Rate | 7 | |||||
| 3-Year FCF Growth Rate | 8.1 | |||||
| 3-Year Book Growth Rate | -14 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 21.47 | |||||
| 9-Day RSI | 26.28 | |||||
| 14-Day RSI | 29.69 | |||||
| 3-1 Month Momentum % | -10.75 | |||||
| 6-1 Month Momentum % | -72.52 | |||||
| 12-1 Month Momentum % | -79.66 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 33.12 | |||||
| Quick Ratio | 33.12 | |||||
| Cash Ratio | 32.67 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.3 | |||||
| Shareholder Yield % | -0.23 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -24.07 | |||||
| ROA % | -23.36 | |||||
| ROIC % | -2781.44 | |||||
| 3-Year ROIIC % | 1003.57 | |||||
| ROC (Joel Greenblatt) % | -10225.3 | |||||
| ROCE % | -25.09 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.55 | |||||
| Price-to-Tangible-Book | 0.55 | |||||
| EV-to-EBIT | 1.53 | |||||
| EV-to-EBITDA | 1.54 | |||||
| EV-to-FCF | 2.22 | |||||
| Price-to-Net-Current-Asset-Value | 0.56 | |||||
| Price-to-Net-Cash | 0.56 | |||||
| Earnings Yield (Greenblatt) % | 65.36 | |||||
| FCF Yield % | -34.1 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:EPIX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ESSA Pharma Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.69 | ||
| Beta | 1.7 | ||
| 3-Year Sharpe Ratio | -0.15 | ||
| 3-Year Sortino Ratio | -0.23 | ||
| Volatility % | 70.67 | ||
| 14-Day RSI | 29.69 | ||
| 14-Day ATR ($) | 0.066142 | ||
| 20-Day SMA ($) | 1.58375 | ||
| 12-1 Month Momentum % | -79.66 | ||
| 52-Week Range ($) | 1.4 - 8.59 | ||
| Shares Outstanding (Mil) | 44.39 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ESSA Pharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ESSA Pharma Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
ESSA Pharma Inc Frequently Asked Questions
What is ESSA Pharma Inc(EPIX)'s stock price today?
The current price of EPIX is $1.48. The 52 week high of EPIX is $8.59 and 52 week low is $1.40.
When is next earnings date of ESSA Pharma Inc(EPIX)?
The next earnings date of ESSA Pharma Inc(EPIX) is 2025-05-14 Est..
Does ESSA Pharma Inc(EPIX) pay dividends? If so, how much?
ESSA Pharma Inc(EPIX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers